[Chemotherapy of pulmonary Mycobacterium kansasii infection].
Mizutani S.
Mizutani S.
Kekkaku. 1996 Sep;71(9):527-31.
Kekkaku. 1996.
PMID: 8914388
Japanese.
A very favorable outcome after chemotherapy of 122 cases of M. kansasii lung disease was reported by Dr. Mizutani, who emphasized RFP as the "Key drug", and concluded that three-drug combination (not two-drug), including RFP (RFP.INH.EB or SM) for 1 year, could be a standa …
A very favorable outcome after chemotherapy of 122 cases of M. kansasii lung disease was reported by Dr. Mizutani, who emphasized RFP …